Literature DB >> 10612016

Economic evaluation of a prostate cancer screening program in France: a decision model.

K Perez-Niddam1, F Thoral, S Charvet-Protat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10612016     DOI： 10.1016/s1040-8428(99)00033-5

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  6 in total

1.  Concordance of couples' prostate cancer screening recommendations from a decision analysis.

Authors:  Scott B Cantor; Robert J Volk; Murray D Krahn; Alvah R Cass; Jawaria Gilani; Susan C Weller; Stephen J Spann
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

2.  Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.

Authors:  E A M Heijnsdijk; T M de Carvalho; A Auvinen; M Zappa; V Nelen; M Kwiatkowski; A Villers; A Páez; S M Moss; T L J Tammela; F Recker; L Denis; S V Carlsson; E M Wever; C H Bangma; F H Schröder; M J Roobol; J Hugosson; H J de Koning
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

Review 3.  Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.

Authors:  A Tawfik
Journal:  Ont Health Technol Assess Ser       Date:  2015-05-01

4.  Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model.

Authors:  Nicolas M Furiak; Robert W Klein; Kristin Kahle-Wrobleski; Eric R Siemers; Eric Sarpong; Timothy M Klein
Journal:  BMC Med Inform Decis Mak       Date:  2010-04-30       Impact factor: 2.796

5.  Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.

Authors:  Nikolai Mühlberger; Kristijan Boskovic; Murray D Krahn; Karen E Bremner; Willi Oberaigner; Helmut Klocker; Wolfgang Horninger; Gaby Sroczynski; Uwe Siebert
Journal:  BMC Public Health       Date:  2017-06-26       Impact factor: 3.295

6.  Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios.

Authors:  Abraham M Getaneh; Eveline A M Heijnsdijk; Monique J Roobol; Harry J de Koning
Journal:  Cancer Med       Date:  2020-08-19       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.